20.01.2016 • News

AkzoNobel Acquires all of EkO Peroxide

AkzoNobel has boosted its position in the North American hydrogen peroxide market with the purchase of all outstanding shares in EkO Peroxide, a joint venture with OCI Peroxygens. Financial details of the transaction were not disclosed. The jv established nine years ago is headquartered at AkzoNobel’s site in Columbus, Mississippi, USA, where it operates a hydrogen peroxide plant with a capacity of 63,500 t/y.

Werner Fuhrmann, AkzoNobel’s executive committee member responsible for specialty chemicals, said the acquisition supports the company’s strategic growth objectives for bleaching chemicals, enabling it to strengthen its integrated platform for the production of hydrogen peroxide and sodium chlorate at the Columbus site. Fuhrmann added that the hydrogen peroxide market in North America has improved significantly in recent years.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read